TOP STORIES

• REGULATORY Chuikyo OKs 7 Drugs Subject to Cost-Effective Review; Re-Pricing to Be Conducted in 2018
  April 27, 2016

• BUSINESS Harvoni Most Prescribed Drug at Acute Hospitals in October-December
  April 27, 2016

• BUSINESS Novartis Looks to Harness Big Data for Indication Expansions: Global Medical Chief
  April 26, 2016

• REGULATORY Making PMDA World’s Most Trusted Regulatory Authority through “Regulatory Innovation”: Chief Executive
  April 25, 2016

• BUSINESS Kaketsuken Continues to Suspend Production as Huge Damages Found
  April 22, 2016

• BUSINESS Around 140 Clinical Trials of Nucleic Acid Drugs Underway Worldwide, with Cancer, Neuropathy, and Myopathy as Main Targets
  April 22, 2016

• BUSINESS Japan’s 1st PCSK9 Inhibitor Hits Market; MHLW Issues Notification to Prevent Hasty Use
  April 21, 2016

• ACADEMIA AMED Study Team Drafting First Guidelines for Diagnosis and Treatment of Post-Stroke Epilepsy
  April 21, 2016

• ACADEMIA 17 Japanese Medical Societies Jointly Recommend HPV Vaccines
  April 20, 2016

• REGULATORY Sales Reps Top Source of Drug Safety Information for Both Clinics and Pharmacies: PMDA Survey
  April 19, 2016

• BUSINESS Wholesalers Say Drug Distributions in Quake-Hit Kumamoto More or Less Stable
  April 19, 2016

• BUSINESS Kaketsuken Halts Operations on April 18-20 after Quake
  April 18, 2016

• REGULATORY Promoting Use of Patient Registries Important in Building Clinical Innovation Network: Health Policy Bureau Chief
  April 18, 2016

• REGULATORY Expedited Review Systems Now in Place in 3 Major Markets, but How Are They Different?
  April 15, 2016

• REGULATORY Indication-Based Front-Loaded Re-Pricing, Coverage Limits Emerge for Pricey Meds: Chuikyo
  April 14, 2016

• REGULATORY Chuikyo OKs Repatha for NHI Price Listing on April 20, Peak Sales Projected at 49 Billion Yen
  April 13, 2016

• BUSINESS Ono Fires Back to 1.75 Trillion Yen Guesstimate, Puts Opdivo Sales at 126 Billion Yen
  April 12, 2016

• ORGANIZATION EFPIA Japan Chief to Call for “Real Dialogue” at Today’s Public-Private Policy Confab
  April 12, 2016

• REGULATORY With Eyes on Pricey Meds, Cost-Shaving Debate Unabated Despite Likely Tax Hike Delay
  April 11, 2016

• BUSINESS Kaketsuken in Talks to Transfer Vaccine Biz to Astellas
  April 8, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 180
• 181
• 182
• 183
• 184
• 185
• 186
• 187
• 188
• …
• Next ›
• 最終 »